AMGN Amgen Inc. - Common Stock

NAS · US · Healthcare · Drug Manufacturers - General · amgen.com

399.79USD-0.81%Mkt Cap: 217.90B $P/E: 25.05Today

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthriti…

Industry Peers

Drug Manufacturers - General

Screen all

LLY

Eli Lilly and Company Common Stock

$1.02TUSDP/E 38.4

JNJ

Johnson & Johnson Common Stock

$617.01BUSDP/E 29.7

ABBV

AbbVie Inc. Common Stock

$464.43BUSDP/E 74.2

MRK

Merck & Company, Inc. Common Stock (new)

Novartis AG Common Stock

AstraZeneca PLC Ordinary Shares

Gilead Sciences, Inc. - Common Stock

$179.47BUSD

NVO

Novo Nordisk A/S Common Stock

$164.79BUSDP/E 9.4

PFE

Pfizer, Inc. Common Stock

$158.45BUSDP/E 36.6

BMY

Bristol-Myers Squibb Company Common Stock

$124.91BUSDP/E 13.5

SNY

Sanofi - American Depositary Shares

$95.65BUSDP/E 21.8

GSK

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Bayer Aktiengesellschaft

$46.94BUSD

Key Statistics

Company

Market Cap217.90B USD

Enterprise Value261.21B USD

Revenue (TTM)38.09B USD

Gross Profit24.71B USD

Net Income (TTM)7.71B USD

Revenue/Share70.68 USD

Last Price399.79 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees31.5K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - General

ISIN—

Valuation

P/E (Trailing)25.05

P/E (Forward)16.48

PEG2.43

EV/EBITDA15.13

EV/Revenue6.86

P/S5.72

P/B18.64

EPS (TTM)16.10

EPS (Forward)24.45

52W Range

269.7774% of range445.87

52W High445.87 USD

52W Low269.77 USD

Profitability

Gross Margin67.25%

Oper. Margin35.55%

EBITDA Margin45.33%

Profit Margin20.98%

ROE89.06%

ROA8.51%

Growth

Revenue Growth9.50%

Earnings Growth64.90%

Cash Flow & Leverage

Operating CF9.96B USD

CapEx (TTM)1.86B USD

FCF Margin22.69%

FCF Yield3.97%

Net Debt43.31B USD

Net Debt/EBITDA2.51

Balance Sheet

Debt/Equity6.31

Current Ratio1.37

Quick Ratio0.95

Book Value/Sh21.62 USD

Cash/Share25.88 USD

Dividends

Fwd Div Rate10.08 USD

Trail. Div Rate9.80 USD

Div. Yield2.50%

5Y Avg Yield3.01%

Payout Ratio60.87%

Ex-Div DateAug 21, 2026

Pay DateSep 11, 2026

Splits

Last Split2:1

Split DateNov 22, 1999

Analyst Consensus

Rating2.6 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)390.94 USD

Upside (mean)-2.2%

Target Range225.00 USD – 500.00 USD

225.00-2.2% to mean500.00

# Analysts29

Ownership

Shares Out.540.63M

Float539.16M

Insiders0.23%

Institutions84.99%

Short Interest

Short Ratio5.4d

Short % Float2.60%

Short % Out.2.60%

Shares Short14.06M

Short (prev mo.)12.04M

Technical

SMA 50409.48 (-2.4%)

SMA 200364.54 (+9.7%)

Beta0.43

S&P 52W Chg14.58%

Avg Vol (30d)2.74M

Avg Vol (10d)3.00M

Technical Indicators

RSI (14)47.9

MACD1.7640

MACD Signal1.3453

MACD Hist.+0.4187

BB Upper447.91 USD

BB Middle405.75 USD

BB Lower363.59 USD

BB Width20.78%

ATR (14)11.01 USD

Vol Ratio (20d)1.15x